Aicardi-Goutières syndrome (AGS) is a rare genetic encephalopathy characterized by neurological and extraneurological involvement. A clinical overlap between AGS and systemic lupus erythematosus (SLE) has been reported. We describe an AGS patient who developed autoimmune manifestations: thyroiditis, cANCA positivity, antiphospholipid antibodies and cerebral ischemia. This first description of antiphospholipid syndrome in a TREX1-mutated patient further expands the clinical spectrum of AGS. Although the clinical overlap with SLE may indicate common pathogenic mechanisms, the autoimmune manifestations in AGS are so extensive that we suggest they should be considered a clinical feature of the disease, rather than a sign of coexistent SLE.

Dysregulation of the immune system in Aicardi-Goutieres syndrome: another example in a TREX1-mutated patient / I. Olivieri, M. Cattalini, D. Tonduti, R. La Piana, C. Uggetti, J. Galli, A. Meini, A. Tincani, D. Moratto, E. Fazzi, U. Balottin, S. Orcesi. - In: LUPUS. - ISSN 0961-2033. - 22:10(2013 Sep), pp. 1064-1069. [10.1177/0961203313498800]

Dysregulation of the immune system in Aicardi-Goutieres syndrome: another example in a TREX1-mutated patient

D. Tonduti;
2013

Abstract

Aicardi-Goutières syndrome (AGS) is a rare genetic encephalopathy characterized by neurological and extraneurological involvement. A clinical overlap between AGS and systemic lupus erythematosus (SLE) has been reported. We describe an AGS patient who developed autoimmune manifestations: thyroiditis, cANCA positivity, antiphospholipid antibodies and cerebral ischemia. This first description of antiphospholipid syndrome in a TREX1-mutated patient further expands the clinical spectrum of AGS. Although the clinical overlap with SLE may indicate common pathogenic mechanisms, the autoimmune manifestations in AGS are so extensive that we suggest they should be considered a clinical feature of the disease, rather than a sign of coexistent SLE.
Aicardi-Goutières syndrome; systemic lupus erythematosus; antiphospholipid syndrome; autoimmune; TREX1
Settore MED/39 - Neuropsichiatria Infantile
set-2013
Article (author)
File in questo prodotto:
File Dimensione Formato  
2013 AGS apl.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 154.23 kB
Formato Adobe PDF
154.23 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/938718
Citazioni
  • ???jsp.display-item.citation.pmc??? 8
  • Scopus 22
  • ???jsp.display-item.citation.isi??? 23
social impact